Unaltered D1, D2, D4, and D5 dopamine receptor mRNA expression and distribution in the spinal cord of the D3 receptor knockout mouse.
Dopamine (DA) acts through five receptor subtypes (D1-D5). We compared expression levels and distribution patterns of all DA mRNA receptors in the spinal cord of wild-type (WT) and loss of function D3 receptor knockout (D3KO) animals. D3 mRNA expression was increased in D3KO, but no D3 receptor protein was associated with cell membranes, supporting the previously reported lack of function. In contrast, mRNA expression levels and distribution patterns of D1, D2, D4, and D5 receptors were similar between WT and D3KO animals. We conclude that D3KO spinal neurons do not compensate for the loss of function of the D3 receptor with changes in the other DA receptor subtypes. This supports use of D3KO animals as a model to provide insight into D3 receptor dysfunction in the spinal cord.
Zhu
Hong
H
Department of Physiology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Clemens
Stefan
S
Sawchuk
Michael
M
Hochman
Shawn
S
D000704:Analysis of Variance; D000818:Animals; D000831:Animals, Newborn; D018507:Gene Expression Regulation, Developmental / Q000235:genetics*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D012333:RNA, Messenger / Q000378:metabolism*; D011954:Receptors, Dopamine / Q000235:genetics* / Q000378:metabolism; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; D050637:Receptors, Dopamine D3 / Q000172:deficiency*; D050638:Receptors, Dopamine D4; D050641:Receptors, Dopamine D5; D013116:Spinal Cord / Q000378:metabolism*
D012333:RNA, Messenger; D011954:Receptors, Dopamine; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; D050637:Receptors, Dopamine D3; D050638:Receptors, Dopamine D4; D050641:Receptors, Dopamine D5
J Clin Invest. 1998 Aug 1;102(3):493-8
9691085
J Neurosci. 2003 Jul 16;23(15):6245-54
12867509
J Neurosci. 2002 Dec 15;22(24):10801-10
12486173
Pharmacol Ther. 1994;64(2):291-370
7878079
Cell Mol Life Sci. 2003 Jul;60(7):1267-80
12943217
Sleep Med. 2004 May;5(3):293-9
15165538
J Neurosci. 2007 Nov 28;27(48):13192-204
18045913
J Neurosci Res. 2007 Apr;85(5):1065-76
17342757
Neurology. 2006 Jul 11;67(1):125-30
16832090
Ann Med. 1998 Aug;30(4):390-6
9783838
Physiol Behav. 1997 Dec 31;63(1):137-41
9402626
Eur J Neurosci. 2004 Mar;19(5):1325-35
15016090
Eur J Neurol. 2000 May;7 Suppl 1:27-31
11054156
Genes Brain Behav. 2002 Aug;1(3):135-41
12884969
Psychopharmacology (Berl). 2005 Nov;183(1):20-30
16136298
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11465-70
15272078
Brain Res. 1982 Jun 24;242(2):247-54
6126249
Prog Neurobiol. 2005 Oct;77(3):139-65
16300874
Eur Neuropsychopharmacol. 2008 Apr;18(4):271-7
17804207
Brain Res Bull. 2003 Jun 30;61(1):109-15
12788214
J Neurosci. 2004 Dec 15;24(50):11337-45
15601940
Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1945-9
8700864
Brain Res. 2002 Jul 26;945(1):9-19
12113946
Dev Neurosci. 1998;20(2-3):188-203
9691193
Neuroscience. 1999;91(3):911-24
10391470
Dev Biol. 1999 Dec 15;216(2):622-34
10642797
Neuropharmacology. 2002 Mar;42(3):396-413
11897118
Neurology. 1999 Mar 23;52(5):938-43
10102409
Neurology. 2000 Apr 25;54(8):1609-16
10762502
Neuroreport. 1996 Jan 31;7(2):513-6
8730818
Methods. 2001 Dec;25(4):402-8
11846609
Neuroscience. 2005;133(2):353-7
15878801
J Mol Neurosci. 2004;22(3):167-78
14997010
Physiol Rev. 1998 Jan;78(1):189-225
9457173
Neuropharmacology. 1996;35(11):1503-19
9025098
Neurosci Biobehav Rev. 1983 Summer;7(2):227-56
6136014
Sleep Med. 2007 Jun;8(4):344-8
17468045
Eur J Pharmacol. 2000 Jul 7;399(2-3):171-81
10884517
Brain Res. 2001 Mar 16;894(2):311-5
11251207
Neuroscience. 2007 Nov 23;149(4):885-97
17936519
Eur J Neurol. 2002 Nov;9 Suppl 3:59-67
12464123
Psychopharmacology (Berl). 2002 Feb;159(4):407-14
11823893
Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2117-22
15684065